NANOBIOTIX to Participate in Multiple Investor Conferences in November

Core Viewpoint - Nanobiotix is actively participating in several upcoming healthcare conferences to showcase its innovative approaches in biotechnology, particularly in cancer treatment and other major diseases [1][2]. Company Overview - Nanobiotix is a late-stage clinical biotechnology company focused on pioneering physics-based therapeutic approaches to improve treatment outcomes for patients [2]. - The company is headquartered in Paris, France, and has been listed on Euronext Paris since 2012 and on the Nasdaq Global Select Market since December 2020 [3]. - Nanobiotix owns over 25 patent families related to three nanotechnology platforms, which have applications in oncology, bioavailability and biodistribution, and central nervous system disorders [3]. Upcoming Conferences - Nanobiotix will participate in the following conferences: - Guggenheim's Inaugural Healthcare Innovation Conference - Date: November 11, 2024 - Time: 4pm ET / 10pm CET - Location: Boston, MA - Presenters: Laurent Levy (CEO) and Bart van Rhijn (CFO) [1] - Stifel Healthcare Conference - Date: November 18, 2024 - Time: 4:45pm ET / 10:45pm CET - Location: New York, NY - Presenter: Bart van Rhijn (CFO) [1] - Jefferies London Healthcare Conference - Date: November 20, 2024 - Time: 1pm GMT / 8am ET / 2pm CET - Location: London, UK - Presenters: Laurent Levy (CEO) and Bart van Rhijn (CFO) [1] Communication and Investor Relations - For further information, Nanobiotix provides contact details for its communications and investor relations departments, emphasizing its commitment to transparency and engagement with stakeholders [4].